Fulgent Genetics, Inc.

El Monte, CA Fulgent Genetics, Inc. Part of Fulgent Therapeutics LLC

UEI
Y9JMAEN8GRK6
CAGE
810T8
Primary NAICS
621511 Medical Laboratories
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
4399 Santa Anita Ave, El Monte, CA 91731, USA
Website
fulgentgenetics.com
Founded
2011
Employees
251-1K
Estimated annual revenue
$50M-$100M
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Fulgent Genetics, Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Genetic testing for VA portland health care system Contract · 36C26024P0864 Veterans Integrated Service Network 20 $133,800

About Fulgent Genetics, Inc.

Fulgent Genetics, Inc. is a for-profit corporate entity based in El Monte, California, specializing in advanced genetic testing, genomic sequencing, and diagnostic services. Registered in SAM.gov since January 2018, the company provides comprehensive genetic and molecular testing solutions primarily to federal agencies through its parent organization and subsidiary, Fulgent Therapeutics LLC. The company operates as a parent entity with a focus on delivering sophisticated genetic testing capabilities across various medical domains, including oncology, medical genetics, and pharmacogenomics.

The company has secured multiple federal contract awards primarily from the Department of Veterans Affairs (VA), Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), and Department of the Army. These contracts encompass a wide range of genetic testing services, including germline genetic testing, next-generation DNA sequencing, clinical genetic testing for conditions like chronic kidney disease, anatomic pathology laboratory services, and specialized molecular testing. Notably, Fulgent Therapeutics has been awarded contracts for SARS-COV-2 genomic sequencing, genetic testing for various VA healthcare systems, and specialized testing services such as multi-gene panels, immunohistochemical staining, and solid tumor sequencing. None of these contracts were designated as set-aside, indicating Fulgent competed in open federal procurement processes.

Fulgent Genetics holds significant Indefinite Delivery Contract (IDC) and Blanket Purchase Agreement (BPA) vehicles with federal agencies. The most prominent is a $99,032,828.20 multiple-award IDC with the VA Strategic Acquisition Center-Frederick, providing national access to germline genetic testing through September 2029. This IDC includes task orders for germline pharmacogenomic molecular testing and supports VA's Oncology, Medical Genetics, and Pharmacogenomics programs. Additionally, the company secured a $500,000 multiple-award BPA with the Department of the Army Medical Center to provide comprehensive genetic testing services at Tripler Army Medical Center in Hawaii. These vehicles demonstrate Fulgent's capability to provide advanced genetic testing technologies across military and veteran healthcare systems, with contract scopes covering various medical specialties including cardiology, dermatology, and oncology.

Quick answers

What is Fulgent Genetics, Inc.'s UEI?

Fulgent Genetics, Inc.'s Unique Entity ID (UEI) in SAM.gov is Y9JMAEN8GRK6.

What is Fulgent Genetics, Inc.'s CAGE code?

Fulgent Genetics, Inc.'s CAGE code is 810T8.

What is Fulgent Genetics, Inc.'s primary NAICS code?

Fulgent Genetics, Inc.'s primary NAICS code is 621511 (Medical Laboratories).

Where is Fulgent Genetics, Inc. located?

Fulgent Genetics, Inc.'s physical address in SAM.gov is 4399 Santa Anita Ave, El Monte, CA 91731, USA.

Is Fulgent Genetics, Inc. registered in SAM.gov?

Fulgent Genetics, Inc.'s SAM.gov registration expired on September 3, 2026.

Who is Fulgent Genetics, Inc.'s parent company?

Fulgent Genetics, Inc. is part of Fulgent Therapeutics LLC.

What is Fulgent Genetics, Inc.'s most recent federal award?

Fulgent Genetics, Inc.'s most recent federal contract award is Genetic testing for VA portland health care system (36C26024P0864), from Veterans Integrated Service Network 20, on August 1, 2024.

On GovTribe

See Fulgent Genetics, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors